Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Major lipids, apolipoproteins, and risk of vascular disease.

Publication ,  Journal Article
Emerging Risk Factors Collaboration, ; Di Angelantonio, E; Sarwar, N; Perry, P; Kaptoge, S; Ray, KK; Thompson, A; Wood, AM; Lewington, S ...
Published in: JAMA
November 11, 2009

CONTEXT: Associations of major lipids and apolipoproteins with the risk of vascular disease have not been reliably quantified. OBJECTIVE: To assess major lipids and apolipoproteins in vascular risk. DESIGN, SETTING, AND PARTICIPANTS: Individual records were supplied on 302,430 people without initial vascular disease from 68 long-term prospective studies, mostly in Europe and North America. During 2.79 million person-years of follow-up, there were 8857 nonfatal myocardial infarctions, 3928 coronary heart disease [CHD] deaths, 2534 ischemic strokes, 513 hemorrhagic strokes, and 2536 unclassified strokes. MAIN OUTCOME MEASURES: Hazard ratios (HRs), adjusted for several conventional factors, were calculated for 1-SD higher values: 0.52 log(e) triglyceride, 15 mg/dL high-density lipoprotein cholesterol (HDL-C), 43 mg/dL non-HDL-C, 29 mg/dL apolipoprotein AI, 29 mg/dL apolipoprotein B, and 33 mg/dL directly measured low-density lipoprotein cholesterol (LDL-C). Within-study regression analyses were adjusted for within-person variation and combined using meta-analysis. RESULTS: The rates of CHD per 1000 person-years in the bottom and top thirds of baseline lipid distributions, respectively, were 2.6 and 6.2 with triglyceride, 6.4 and 2.4 with HDL-C, and 2.3 and 6.7 with non-HDL-C. Adjusted HRs for CHD were 0.99 (95% CI, 0.94-1.05) with triglyceride, 0.78 (95% CI, 0.74-0.82) with HDL-C, and 1.50 (95% CI, 1.39-1.61) with non-HDL-C. Hazard ratios were at least as strong in participants who did not fast as in those who did. The HR for CHD was 0.35 (95% CI, 0.30-0.42) with a combination of 80 mg/dL lower non-HDL-C and 15 mg/dL higher HDL-C. For the subset with apolipoproteins or directly measured LDL-C, HRs were 1.50 (95% CI, 1.38-1.62) with the ratio non-HDL-C/HDL-C, 1.49 (95% CI, 1.39-1.60) with the ratio apo B/apo AI, 1.42 (95% CI, 1.06-1.91) with non-HDL-C, and 1.38 (95% CI, 1.09-1.73) with directly measured LDL-C. Hazard ratios for ischemic stroke were 1.02 (95% CI, 0.94-1.11) with triglyceride, 0.93 (95% CI, 0.84-1.02) with HDL-C, and 1.12 (95% CI, 1.04-1.20) with non-HDL-C. CONCLUSION: Lipid assessment in vascular disease can be simplified by measurement of either total and HDL cholesterol levels or apolipoproteins without the need to fast and without regard to triglyceride.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

November 11, 2009

Volume

302

Issue

18

Start / End Page

1993 / 2000

Location

United States

Related Subject Headings

  • Vascular Diseases
  • Triglycerides
  • Stroke
  • Risk Factors
  • Regression Analysis
  • Proportional Hazards Models
  • Middle Aged
  • Male
  • Lipids
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Emerging Risk Factors Collaboration, ., Di Angelantonio, E., Sarwar, N., Perry, P., Kaptoge, S., Ray, K. K., … Danesh, J. (2009). Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 302(18), 1993–2000. https://doi.org/10.1001/jama.2009.1619
Emerging Risk Factors Collaboration, John, Emanuele Di Angelantonio, Nadeem Sarwar, Philip Perry, Stephen Kaptoge, Kausik K. Ray, Alexander Thompson, et al. “Major lipids, apolipoproteins, and risk of vascular disease.JAMA 302, no. 18 (November 11, 2009): 1993–2000. https://doi.org/10.1001/jama.2009.1619.
Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009 Nov 11;302(18):1993–2000.
Emerging Risk Factors Collaboration, John, et al. “Major lipids, apolipoproteins, and risk of vascular disease.JAMA, vol. 302, no. 18, Nov. 2009, pp. 1993–2000. Pubmed, doi:10.1001/jama.2009.1619.
Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009 Nov 11;302(18):1993–2000.
Journal cover image

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

November 11, 2009

Volume

302

Issue

18

Start / End Page

1993 / 2000

Location

United States

Related Subject Headings

  • Vascular Diseases
  • Triglycerides
  • Stroke
  • Risk Factors
  • Regression Analysis
  • Proportional Hazards Models
  • Middle Aged
  • Male
  • Lipids
  • Humans